RIVERMARK MEDICAL ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN USE OF ITS FLOSTENT SYSTEM FOR SYMPTOMATIC BPH
Company to expand clinical program as all treated patients experienced rapid symptom improvementMILWAUKEE, Jan. 10, 2023 /PRNewswire/ -- Rivermark...
Source: businessinsider.com